Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion.

Area of Science:

• Neuro-oncology
• Cancer Biology
• Pharmacology

Background:

• Primary glioblastoma multiforme (GBM) remains largely incurable in adult patients.
• Treatment failures stem from genetic aberrations, molecular heterogeneity, and clonal evolution within GBM.
• These factors contribute to drug resistance, incomplete surgical resection, and ineffective radiotherapy.

Purpose of the Study:

• To explore Withaferin A as a potential therapeutic agent for glioblastoma multiforme.
• To investigate the efficacy of Withaferin A, alone or in combination, in addressing GBM's aggressive characteristics.

Main Methods:

• The study focuses on the molecular mechanisms underlying GBM progression, including cell motility, migration, and invasion.
• It proposes the use of Withaferin A and pleiotropic drugs to counteract these mechanisms.

Main Results:

• Withaferin A and combination therapies show promise in targeting pathways that promote tumor cell motility, migration, invasion, and proliferation.
• These agents may overcome key challenges leading to current clinical treatment failures.

Conclusions:

• Withaferin A presents a potential therapeutic avenue for glioblastoma multiforme.
• Combination therapies targeting aberrant molecules and pathways could improve treatment outcomes for GBM.